Pfizer COVID-19 vaccine trial subject presses FDA to greenlight shots - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 51%

Italia Notizia Notizia

A Pfizer vaccine trial participant who's been vaccinated for 5 months said 'let's roll,' pressing for the FDA to greenlight the first coronavirus shot course

Oil markets surged in the hours after Pfizer announced positive results from its coronavirus vaccine study.Vaccines and Related Biological Products Advisory Committee is meeting to discuss Pfizer'sDuring the meeting, one person who was part of Pfizer's study said he believes the vaccine should receive emergency use authorization immediately to help save lives during the pandemic.

"I understand the concerns about whether or not people will trust the vaccines, but there will always be some holdouts," Fein said during the hearing. "Most Americans will take the vaccine voluntarily, as long as we're honest, don't talk down to them, and treat them like autonomous adults."Evan Fein can't know for sure, but he is pretty certain he got Pfizer's experimental coronavirus vaccine about five months ago.

If Pfizer's shot is granted an emergency use authorization by the FDA, it would be the first vaccine in use in the US for the pandemic. Fein compared the pandemic's devastation to another American tragedy: the terrorist attacks on September 11, 2001. He noted the daily death toll from the virus now exceeds the number of lives lost on 9/11.

But he stressed he was impressed with the study follow-up protocol, and how seriously doctors and researchers took his notes.

 

Grazie per il tuo commento. Il tuo commento verrà pubblicato dopo essere stato esaminato.

MxolisiBob

Long term means over a few years not months. And still no answer is given to those with a medical history. All trials are being done on healthy people which is the only references.

Better, let's ban the Public Readiness and Emergency Preparedness Act that gives immunity from liability against any harm caused by te vaccine

It is reassuring to hear trial participants pushing to get the vaccine out to more people. A researcher i was watching the other night feared that side effects from the first dosage would deter some from returning for their second, but no long term symptoms is relieving. BCSTT

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

 /  🏆 729. in İT

Italia Ultime Notizie, Italia Notizie